NOVA

SN68 Price

About NOVA (sn68)

NOVA is a decentralized, merit-based competition engine for artificial intelligence-driven drug discovery, operating as Subnet 68 on the Bittensor network.

• The project utilizes a decentralized machine learning network to accelerate the identification of candidate molecules for pharmaceutical development.
• The protocol employs an adversarial incentive structure where participants compete to optimize binding affinity for specific protein targets.
• NOVA leverages a model-agnostic architecture, allowing for the integration of various predictive models and chemical diversity metrics.

What Is NOVA

NOVA is a decentralized platform designed to revolutionize the early stages of pharmaceutical research through distributed computing and competitive AI. Built on the Bittensor ecosystem, it functions as a specialized environment where miners and validators collaborate to solve complex chemical problems. The primary mission of the project is to create a self-improving drug discovery engine that identifies potent, novel, and diverse molecular compounds more efficiently than traditional centralized methods.

Value moves through the system as miners contribute computational search efforts, which are then evaluated and rewarded based on their contribution to the network's collective intelligence. The sn68 token is put to work as the primary incentive for these participants, rewarding those who successfully identify high-potential molecules. As the ecosystem grows, this competitive framework scales by increasing the breadth of chemical libraries searched and the sophistication of the predictive models used.

What Makes NOVA Unique

• Adversarial Discovery: Unlike passive screening, NOVA uses an adversarial framework that rewards miners for finding molecules that perform well against specific targets while penalizing those that lack specificity or structural novelty.
• Chemical Diversity Metrics: The protocol incorporates advanced metrics such as Molecular Access System (MACCS) key fingerprints and the Shannon diversity index to ensure the discovered molecules are structurally diverse, reducing the risk of redundant exploration.
• Model-Agnostic Engine: The system is designed to be compatible with various oracles and prediction models, such as PSICHIC, a Graph Neural Network (GNN) based oracle that predicts binding affinity.
• Epoch-Based Competition: The use of weekly target locks and hour-scale epochs creates a high-frequency feedback loop, encouraging rapid iteration and lead optimization.

What Can You Use NOVA for?

• Incentivizing Research: The sn68 token is used to reward miners who contribute high-quality molecular candidates to the drug discovery challenges.
• Staking and Validation: Participants can stake sn68 to participate in the validation process, ensuring the integrity and accuracy of the scoring mechanisms on Subnet 68.
• Accessing Discovery Data: The protocol facilitates access to a decentralized library of molecular compounds, which can be leveraged for further pharmaceutical development and lead optimization in the Decentralized Science (DeSci) sector.

How Does NOVA Work?

NOVA operates as a technical infrastructure layer within the Bittensor network. The core mechanism is built around a validator-miner feedback loop. Miners perform virtual screening against a massive library of compounds, such as the SAVI 2020 library, which contains approximately 1.75 billion molecules. They submit their best candidates for a specific protein target provided by the network.

Validators then use an oracle, typically a Graph Neural Network (GNN)—a type of AI that processes data structured as graphs, like molecular bonds—to score the submissions. The scoring is deterministic and adversarial, meaning it accounts for both the binding potency (how well a molecule sticks to a target) and structural novelty. Participants must pay protocol service fees in the form of sn68 to interact with the subnet's specialized features, ensuring the sustainability of the decentralized infrastructure.

Team Info and Investors

The project is developed by Metanova Labs, an organization focused on the intersection of decentralized AI and biotechnology. While the source material does not specify individual founders or major early investors, the project operates within the broader Bittensor ecosystem, benefiting from its decentralized governance and security model.

Where can you buy NOVA?

SN68 tokens can be traded on decentralized exchanges. The most popular exchange to buy and trade NOVA is Subnet Tokens, where the most active trading pair SN68/SN0 has a trading volume of $806,584.23 in the last 24 hours.

What is the daily trading volume of NOVA (SN68)?

The trading volume of NOVA (SN68) is $806,584.23 in the last 24 hours, representing a -22.80% decrease from one day ago and signalling a recent fall in market activity. Check out CoinGecko’s list of highest volume cryptocurrencies.

What is the highest and lowest price for NOVA (SN68)?

NOVA (SN68) reached an all-time high of $14.03 and an all-time low of $1.72. It’s now trading -65.70% below that peak and 178.90% above its lowest price.

What is the market cap of NOVA (SN68)?

Market capitalization of NOVA (SN68) is $21,438,066 and is ranked #769 on CoinGecko today. Market cap is measured by multiplying token price with the circulating supply of SN68 tokens (4.5 Million tokens are tradable on the market today).

What is the fully diluted valuation of NOVA (SN68)?

The fully diluted valuation (FDV) of NOVA (SN68) is $21,438,066. This is a statistical representation of the maximum market cap, assuming the maximum number of 21 Million SN68 tokens are in circulation today. Depending on how the emission schedule of SN68 tokens are designed, it might take multiple years before FDV is realized.

How does the price performance of NOVA compare against its peers?

With a price decline of -8.70% in the last 7 days, NOVA (SN68) is underperforming the global cryptocurrency market which is down -2.20%, while underperforming when compared to similar Artificial Intelligence (AI) cryptocurrencies which are down -7.60%.